Migraine Device Shows Promise for Veterans
A study of 466 veterans found a remote neuromodulation device provided migraine relief with few adverse events.
Updated on Nov. 3, 2026 in Stroke
Live Poll
Would you be willing to try a drug-free device before taking migraine medication?
A study of 466 veterans receiving Veterans Health Administration care found a nonpharmacologic neuromodulation device helped manage migraine attacks. Across 28,274 treatments, 76.7% of patients consistently managed attacks using the device.
Why it matters
Veterans have a higher likelihood of coexisting conditions such as insomnia, chronic pain, and mood disorders, and daily military gear wear, mission-related exposures, and trauma can lead to musculoskeletal pain. The findings suggest a drug-free option may be useful for a population with complex pain needs.
The analysis covered 28,274 treatments from 466 veterans between November 2020 and February 2026, with the device used as stand-alone therapy in 60.9% of treatments. Only 2 patients reported any adverse event, though the source does not report a control-group comparison.
The players
Veterans Health Administration
The Veterans Health Administration is the federal healthcare system serving U.S. military veterans through the Department of Veterans Affairs.
Central Virginia VA Health Care System
The Central Virginia VA Health Care System is a regional VA medical network based in Richmond, Virginia.
The details
The device, Nerivio REN, stimulates fibers in the upper arm to trigger a pain inhibitory response and is worn much like a blood pressure cuff. Veterans who started treatment within 1 hour of migraine onset showed more benefit than those treated later.
Timeline
November 2020 to February 2026: Study period covering 28,274 device treatments.
2023: Clinicians began regularly prescribing neuromodulation devices to veterans.
November 3, 2026: Article published reporting study findings.
Health Landscape
The study adds real-world evidence to the VA's expanding use of nonpharmacologic migraine devices, one of four options the agency offers. It reflects a broader shift toward drug-free treatments for a veteran population with high rates of chronic pain and coexisting conditions.
Veterans with migraine may have a drug-free option that is worn on the arm and used as stand-alone therapy or alongside over-the-counter pain relievers. Starting treatment within 1 hour of migraine onset appeared to offer more benefit than treating later.
The takeaway
Timing matters: the study found veterans who began treatment within an hour of migraine onset benefited more. Patients considering neuromodulation should discuss options with their clinicians.
Further reading
Explore more on Stroke for related neurological health coverage.
Source note: This article includes information reported by Medscape.
Live Poll
Would you be willing to try a drug-free device before taking migraine medication?
